Titre : Cellules THP-1

Cellules THP-1 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Science
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules THP-1 : Questions médicales les plus fréquentes", "headline": "Cellules THP-1 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules THP-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-26", "dateModified": "2025-03-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules THP-1" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lignée cellulaire tumorale", "url": "https://questionsmedicales.fr/mesh/D045744", "about": { "@type": "MedicalCondition", "name": "Lignée cellulaire tumorale", "code": { "@type": "MedicalCode", "code": "D045744", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.251.860.180" } } }, "about": { "@type": "MedicalCondition", "name": "Cellules THP-1", "alternateName": "THP-1 Cells", "code": { "@type": "MedicalCode", "code": "D000074084", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Terumasa Ikeda", "url": "https://questionsmedicales.fr/author/Terumasa%20Ikeda", "affiliation": { "@type": "Organization", "name": "2 Institute for Molecular Virology, Minneapolis, MN 55455, USA." } }, { "@type": "Person", "name": "Michael A Carpenter", "url": "https://questionsmedicales.fr/author/Michael%20A%20Carpenter", "affiliation": { "@type": "Organization", "name": "3 Center for Genome Engineering, Minneapolis, MN 55455, USA." } }, { "@type": "Person", "name": "William L Brown", "url": "https://questionsmedicales.fr/author/William%20L%20Brown", "affiliation": { "@type": "Organization", "name": "4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA." } }, { "@type": "Person", "name": "Reuben S Harris", "url": "https://questionsmedicales.fr/author/Reuben%20S%20Harris", "affiliation": { "@type": "Organization", "name": "3 Center for Genome Engineering, Minneapolis, MN 55455, USA." } }, { "@type": "Person", "name": "Valentina Galbiati", "url": "https://questionsmedicales.fr/author/Valentina%20Galbiati", "affiliation": { "@type": "Organization", "name": "Università Degli Studi di Milano, Laboratory of Toxicology, Dipartimento di Scienze Politiche ed Ambientali, Milan, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Long-term outcomes of anatomical and extra-anatomical bypass for the treatment of unilateral iliac artery lesions a systematic review aggregated data and individual participant data meta-analysis.", "datePublished": "2024-04-06", "url": "https://questionsmedicales.fr/article/38588957", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.avsg.2024.02.007" } }, { "@type": "ScholarlyArticle", "name": "A BAYESIAN HIERARCHICAL SMALL AREA POPULATION MODEL ACCOUNTING FOR DATA SOURCE SPECIFIC METHODOLOGIES FROM AMERICAN COMMUNITY SURVEY, POPULATION ESTIMATES PROGRAM, AND DECENNIAL CENSUS DATA.", "datePublished": "2024-04-05", "url": "https://questionsmedicales.fr/article/39323985", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1214/23-aoas1849" } }, { "@type": "ScholarlyArticle", "name": "The impact of different data handling strategies in exploratory and confirmatory factor analysis of diary measures: an evaluation using simulated and real-world asthma nighttime symptoms diary data.", "datePublished": "2024-02-14", "url": "https://questionsmedicales.fr/article/38354337", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/10543406.2024.2310312" } }, { "@type": "ScholarlyArticle", "name": "Can we identify the prevalence of perinatal mental health using routinely collected health data?: A review of publicly available perinatal mental health data sources in England.", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/38249845", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/lrh2.10374" } }, { "@type": "ScholarlyArticle", "name": "\"Data makes the story come to life:\" understanding the ethical and legal implications of Big Data research involving ethnic minority healthcare workers in the United Kingdom-a qualitative study.", "datePublished": "2022-12-16", "url": "https://questionsmedicales.fr/article/36527096", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12910-022-00875-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Cellules cultivées", "item": "https://questionsmedicales.fr/mesh/D002478" }, { "@type": "ListItem", "position": 4, "name": "Cellules cancéreuses en culture", "item": "https://questionsmedicales.fr/mesh/D014407" }, { "@type": "ListItem", "position": 5, "name": "Lignée cellulaire tumorale", "item": "https://questionsmedicales.fr/mesh/D045744" }, { "@type": "ListItem", "position": 6, "name": "Cellules THP-1", "item": "https://questionsmedicales.fr/mesh/D000074084" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules THP-1 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules THP-1", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules THP-1", "description": "Comment identifier les cellules THP-1 en laboratoire ?\nQuels tests sont utilisés pour caractériser les cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être contaminées ?\nQuelle est la source des cellules THP-1 ?\nLes cellules THP-1 sont-elles sensibles à des médicaments ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Data+Science&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules THP-1", "description": "Quels sont les marqueurs d'activation des cellules THP-1 ?\nLes cellules THP-1 montrent-elles des signes d'inflammation ?\nComment les cellules THP-1 réagissent-elles aux pathogènes ?\nLes cellules THP-1 peuvent-elles se différencier ?\nQuels effets ont les cytokines sur les cellules THP-1 ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Data+Science&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules THP-1", "description": "Comment prévenir la contamination des cellules THP-1 ?\nQuelles conditions de culture sont idéales pour les cellules THP-1 ?\nLes cellules THP-1 nécessitent-elles des soins particuliers ?\nComment assurer la viabilité des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être cryogénisées ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Data+Science&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules THP-1", "description": "Comment les cellules THP-1 sont-elles utilisées en recherche ?\nPeut-on modifier génétiquement les cellules THP-1 ?\nQuels traitements sont testés sur les cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être utilisées pour des tests de toxicité ?\nComment les cellules THP-1 aident-elles à comprendre les maladies ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Data+Science&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules THP-1", "description": "Quelles complications peuvent survenir lors de l'utilisation des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles induire des réponses immunitaires indésirables ?\nQuels risques sont associés à la manipulation des cellules THP-1 ?\nLes cellules THP-1 peuvent-elles être affectées par des agents externes ?\nComment minimiser les complications lors des expériences avec THP-1 ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Data+Science&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules THP-1", "description": "Quels facteurs influencent la croissance des cellules THP-1 ?\nLes cellules THP-1 sont-elles sensibles à des agents environnementaux ?\nQuels traitements peuvent affecter les cellules THP-1 ?\nLes cellules THP-1 sont-elles affectées par le stress oxydatif ?\nQuels facteurs génétiques influencent les cellules THP-1 ?", "url": "https://questionsmedicales.fr/mesh/D000074084?mesh_terms=Data+Science&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les cellules THP-1 en laboratoire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules THP-1 sont identifiées par leur morphologie et leur expression de marqueurs spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour caractériser les cellules THP-1 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme la cytométrie en flux et l'immunofluorescence sont utilisés." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles être contaminées ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comme toutes les lignées cellulaires, elles peuvent être contaminées par des bactéries ou des mycoplasmes." } }, { "@type": "Question", "name": "Quelle est la source des cellules THP-1 ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules THP-1 proviennent de la moelle osseuse d'un patient atteint de leucémie." } }, { "@type": "Question", "name": "Les cellules THP-1 sont-elles sensibles à des médicaments ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour tester la sensibilité à divers agents pharmacologiques." } }, { "@type": "Question", "name": "Quels sont les marqueurs d'activation des cellules THP-1 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs incluent CD14, CD11b et CD68, indiquant leur activation." } }, { "@type": "Question", "name": "Les cellules THP-1 montrent-elles des signes d'inflammation ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles produisent des cytokines pro-inflammatoires lorsqu'elles sont activées." } }, { "@type": "Question", "name": "Comment les cellules THP-1 réagissent-elles aux pathogènes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles phagocytent les pathogènes et sécrètent des médiateurs inflammatoires." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles se différencier ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent se différencier en macrophages sous l'influence de certains facteurs." } }, { "@type": "Question", "name": "Quels effets ont les cytokines sur les cellules THP-1 ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les cytokines modulent leur activation et leur capacité à produire d'autres médiateurs." } }, { "@type": "Question", "name": "Comment prévenir la contamination des cellules THP-1 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des techniques aseptiques et vérifier régulièrement la pureté cellulaire." } }, { "@type": "Question", "name": "Quelles conditions de culture sont idéales pour les cellules THP-1 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elles nécessitent un milieu riche en nutriments et une température contrôlée." } }, { "@type": "Question", "name": "Les cellules THP-1 nécessitent-elles des soins particuliers ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles doivent être manipulées avec précaution pour éviter le stress cellulaire." } }, { "@type": "Question", "name": "Comment assurer la viabilité des cellules THP-1 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir des conditions optimales de culture et éviter les cycles de congélation-décongélation." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles être cryogénisées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être cryogénisées pour une conservation à long terme." } }, { "@type": "Question", "name": "Comment les cellules THP-1 sont-elles utilisées en recherche ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont utilisées pour étudier les mécanismes immunitaires et tester des médicaments." } }, { "@type": "Question", "name": "Peut-on modifier génétiquement les cellules THP-1 ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme CRISPR peuvent être utilisées pour modifier leur génome." } }, { "@type": "Question", "name": "Quels traitements sont testés sur les cellules THP-1 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements anti-inflammatoires et anticancéreux sont souvent testés." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles être utilisées pour des tests de toxicité ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont souvent utilisées pour évaluer la toxicité des composés chimiques." } }, { "@type": "Question", "name": "Comment les cellules THP-1 aident-elles à comprendre les maladies ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles modélisent des maladies inflammatoires et infectieuses pour étudier les mécanismes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir lors de l'utilisation des cellules THP-1 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des résultats biaisés peuvent survenir si les cellules sont contaminées ou mal caractérisées." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles induire des réponses immunitaires indésirables ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent parfois produire des réponses immunitaires non spécifiques." } }, { "@type": "Question", "name": "Quels risques sont associés à la manipulation des cellules THP-1 ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le risque principal est la contamination croisée avec d'autres lignées cellulaires." } }, { "@type": "Question", "name": "Les cellules THP-1 peuvent-elles être affectées par des agents externes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des agents comme les toxines ou les médicaments peuvent altérer leur fonction." } }, { "@type": "Question", "name": "Comment minimiser les complications lors des expériences avec THP-1 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Suivre des protocoles stricts et effectuer des contrôles réguliers de qualité." } }, { "@type": "Question", "name": "Quels facteurs influencent la croissance des cellules THP-1 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme la température, le pH et la composition du milieu influencent leur croissance." } }, { "@type": "Question", "name": "Les cellules THP-1 sont-elles sensibles à des agents environnementaux ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être affectées par des agents chimiques ou physiques dans leur environnement." } }, { "@type": "Question", "name": "Quels traitements peuvent affecter les cellules THP-1 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements comme les cytokines ou les médicaments peuvent moduler leur activité." } }, { "@type": "Question", "name": "Les cellules THP-1 sont-elles affectées par le stress oxydatif ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress oxydatif peut altérer leur fonction et leur viabilité." } }, { "@type": "Question", "name": "Quels facteurs génétiques influencent les cellules THP-1 ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des variations génétiques peuvent affecter leur réponse aux stimuli immunitaires." } } ] } ] }

Sources (10000 au total)

Long-term outcomes of anatomical and extra-anatomical bypass for the treatment of unilateral iliac artery lesions a systematic review aggregated data and individual participant data meta-analysis.

We investigated the long-term safety and efficacy of anatomical and extra-anatomical bypass for the treatment of unilateral iliac artery disease.... A systematic search on PubMed, Scopus and Web of science for articles published by June 2023 was performed. We implemented a two-stage individual participant data (IPD) meta-analysis and pooled surviv... Ten studies encompassing 1907 patients were included. The five- and ten-year pooled primary patency for anatomical bypass was 83.27% (95% CI:69.99- 99.07) and 77.30% (95% CI:60.32- 99.04), with a mean... While we have demonstrated favorable long-term primary and secondary patency outcomes for both surgical techniques, anatomical bypass exhibited a reduced risk of primary patency loss potentially refle...

The impact of different data handling strategies in exploratory and confirmatory factor analysis of diary measures: an evaluation using simulated and real-world asthma nighttime symptoms diary data.

Daily diaries are an important modality for patient-reported outcome assessment. They typically comprise multiple questions, so understanding their underlying structure is key to appropriate analysis ... The above strategies were evaluated in a simulated dataset via exploratory and confirmatory factor modelling by comparing their impact on various estimates (i.e., inter-item correlations, factor loadi... Both single day and item average strategies resulted in biased factor loadings. The former displayed lower overall bias (single day: 0.064; item average: 0.121) and mean square error (single day: 0.00... Our findings suggest that a multilevel approach can enhance our insight when evaluating the structural properties of daily diary data; however, implementation challenges still remain. Our work offers ...

Can we identify the prevalence of perinatal mental health using routinely collected health data?: A review of publicly available perinatal mental health data sources in England.

Perinatal mental health (PMH) conditions affect around one in four women, and may be even higher in women from some ethnic minority groups and those living in low socioeconomic circumstances. Poor PMH... A review of data sources was completed by searching NHS Digital (now NHS England), Public Health England and other national PMH resources, performing keyword searches online, and research team knowled... We found a PMH data 'blind spot' with significant inadequacies in the utility of all identified data sources, making it impossible to provide information on the prevalence of PMH in England and unders... To enhance the utility of publicly available routine data to provide PMH prevalence rates requires improved mandatory PMH data capture in universal services, available publicly via one platform and in...

"Data makes the story come to life:" understanding the ethical and legal implications of Big Data research involving ethnic minority healthcare workers in the United Kingdom-a qualitative study.

The aim of UK-REACH ("The United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers") is to understand if, how, and why healthcare workers (HCWs) in the United Kingdom (...

Determination of objective taste perception among Iranian medical sciences students during COVID‑19 pandemic in Yazd, Eastern Iran: a case-control pilot study.

Taste disorders in patients suffering from COVID-19 were popular. Some people even after recovery report residual effects of loss of smell and taste. This study aimed to investigate the taste Percepti... The case-control study evaluated 50 Medical Sciences students with a history of COVID-19 infection, as confirmed by the Novel Coronavirus (2019-nCOV) CFX96™ Real-Time PCR Detection System. The other p... In this survey, 54% of participants were male and 46% were female, the mean age of participants was 22.96 ± 5 years. The results showed a significant difference in the sweet and bitter taste perceptio... Our findings could provide important insights into taste perception. The history of dietary supplementation may influence how sweetness and saltiness are perceived. There was a noticeable difference i...

Knowledge, Attitude, and Practice (KAP) Status toward Clinical Reasoning and Evidence-Based Medicine among the Medical Interns and Gynecology Residents of Iran University of Medical Sciences.

Clinical reasoning and evidence-based medicine (EBM) are important concepts in modern medicine.... We performed this study to investigate the knowledge, attitude, and practice (KAP) status toward clinical reasoning and EBM among the medical interns and gynecology resident physicians of Iran Univers... A cross-sectional study (Tehran, Iran, first half of 2022) was conducted based on two researcher-made questionnaires consisting of three components for each including clinical reasoning attitude (CR-A... A total of 60 individuals participated. The mean score was good for CR-A, moderate for CR-K, moderate for CR-P, good for EBM-A, moderate for EBM-K, and moderate for EBM-P. The total score was moderate... The total score and many of the KAP components had moderate status for clinical reasoning and EBM. Planning on the associated factors should be regarded in the future. Such questionnaires are suggeste...